Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.74829 | 31 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.71226 | 31 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.73266 | 32 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.69126 | 33 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.7388 | 35 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.74318 | 29 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.75554 | 31 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.70984 | 32 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.69892 | 32 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.71826 | 32 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.33182 | 14 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.70245 | 32 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.71861 | 32 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.72028 | 32 |